Reason: 59 M with cirrhosis 6.5cm x 3.8cm x 6cm mass in the liver. Triple phase CT to evaluate for HCC and/or evaluate the etiology History: 59 M with cirrhosis 6.5cm x 3.8cm x 6cm mass in the liver. Triple phase CT to evaluate for HCC and/or evaluate the etiology ABDOMEN:LIVER, BILIARY TRACT: Cirrhotic morphology of the liver. Confluent fibrosis and significant atrophy of the right lobe of the liver. Left lobe hypertrophy. In the left lobe of the liver, there is a 3.9 x 6.2 x 5.1 cm lobulated mass (series 5 image 24, series 3 image 40). This mass demonstrates T2 slightly hyperintense and T1 hypointense signal with peripheral early arterial enhancement that progressively fills in. No definite washout seen on delayed images.Cholelithiasis.SPLEEN: Splenomegaly with the spleen measuring 17.5 cm in the craniocaudal dimension. Perisplenic varices.PANCREAS: No significant abnormality noted.ADRENAL GLANDS: No significant abnormality noted.KIDNEYS, URETERS: No significant abnormality noted.RETROPERITONEUM, LYMPH NODES: Mildly enlarged cardiophrenic lymph nodes.BOWEL, MESENTERY: Esophageal varices. Perigastric varices.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: Trace pleural effusions. No ascites.
1.Mass in the left lobe of the liver with signal and enhancement characteristics more consistent with cholangiocarcinoma. If clinically indicated, this mass is amenable to percutaneous biopsy.2.Cirrhotic morphology. Significant confluent fibrosis and atrophy of the right lobe of the liver. Findings compatible with portal hypertension.